More than 37 million people in the United States are living with diabetes, and most of them have type 2 diabetes. While this condition is more common in older adults, it’s now being diagnosed in younger people as well.
Managing type 2 diabetes usually involves medication, and in many cases, daily insulin injections to control blood sugar. But a new treatment called ReCET might offer a simpler, less burdensome way to manage the disease.
ReCET stands for Re-cellularization via Electroporation Therapy, and it’s a groundbreaking approach developed by researchers aiming to change how we treat type 2 diabetes.
The method uses gentle electrical pulses to target the inner lining of the small intestine. The idea is that by changing this tissue, the body may start responding better to insulin—the hormone that helps control blood sugar.
The ReCET procedure is performed using an endoscope, a thin, flexible tube that goes through the mouth to reach the small intestine. This means no surgery is needed. Once in place, the device delivers controlled electric pulses to the surface of the intestine. This process “resets” the cells, potentially improving how the body uses insulin.
In a recent study, 14 people with type 2 diabetes received the ReCET treatment. After the procedure, they followed a special diet for two weeks, and then began taking a diabetes medication called semaglutide. This drug is already known to help lower blood sugar, and in some cases, it allows patients to stop using insulin—but it doesn’t work for everyone.
The early results from the ReCET study were very promising. Most of the participants were able to stop using insulin injections altogether while still keeping their blood sugar levels under control. Researchers believe ReCET helps the body become more sensitive to insulin, meaning it can do a better job of keeping blood sugar in a healthy range without needing as much outside help.
This new treatment could be a major breakthrough. For people who rely on insulin every day, the possibility of managing diabetes without daily shots could mean a huge improvement in comfort, convenience, and quality of life.
However, it’s important to remember that this is just the beginning. The ReCET trial was small, and more research is needed to make sure the treatment is safe, effective, and long-lasting.
While new treatments like ReCET bring hope, managing type 2 diabetes still depends heavily on lifestyle choices. Eating healthy foods, staying active, quitting smoking, and limiting alcohol are all important parts of diabetes care. These habits not only help control blood sugar but also reduce the risk of complications like heart disease and nerve damage.
Researchers are also exploring other exciting areas, like how the MIND diet may help protect against vision loss and how metformin, a common diabetes drug, might slow down mental decline in older adults with diabetes.
The ReCET findings, shared at Digestive Disease Week in 2023, could mark the beginning of a new chapter in diabetes treatment. While more studies are needed, the early success of this therapy offers hope for millions of people who are looking for easier, more effective ways to manage their condition.
In short, ReCET could be a game-changer in the fight against type 2 diabetes. If future trials continue to show strong results, this therapy might one day help people live healthier lives—without the daily burden of insulin injections.
If you care about diabetes, please read studies about the cooking connection between potatoes and diabetes, and low calorie diets may help reverse type 2 diabetes.
For more health information, please see recent studies about protein power: a new ally in diabetes management, and pineapple and diabetes: A sweet surprise.
Copyright © 2025 Knowridge Science Report. All rights reserved.
